Shares of OSR Health, Inc. closed at $0.5900 on August 17, up 86.71% from a previous close of $0.3160, after the company filed its quarterly report for the period ended June 30, 2026. Dollar volume was $208,235,745 across 576,466 trades. The company's free float stands at 19,424,149 shares, representing 55.3% of shares outstanding. Short volume on the session was 149,593,848 shares, equal to 58.51% of reported volume.
The 10-Q, filed August 14, shows net sales of $315,669 in the second quarter of 2026, compared with $1,135,517 in the same period a year earlier. For the first six months of 2026, net sales were $799,727, against $1,896,789 in the first half of 2025. The filing gives no explanation for the decline.
Despite lower revenue, the net loss narrowed. The second-quarter net loss was $1,004,038, compared with $5,225,198 in the second quarter of 2025. For the first six months, the net loss was $4,471,212, against $16,618,012 a year earlier. The prior-year figure included $8,611,114 in merger and acquisition costs related to the business combination completed in February 2025.
Cash at June 30, 2026 stood at $1,499,603, down from $1,700,273 at December 31, 2025. Operating activities consumed $3,422,481 in cash during the first half of the year. At that pace, the cash on hand covers a fraction of one quarter of operating outflows. The filing does not state how the company intends to fund ongoing operations beyond what is noted about existing financing activities.
The share count has grown materially. Shares outstanding were 35,118,692 as of August 10, 2026, up from 26,597,769 at December 31, 2025. The increase reflects two tranches of issuances under an equity line of credit — a financing arrangement in which a company draws cash by issuing shares to a committed buyer — as well as shares issued to acquire Woori-IO Co., Ltd., a Korean medical device developer added to the group in January 2026. The ELOC issuances in the first half raised a combined $2,526,699 in gross proceeds, according to the filing.
The accumulated deficit reached $40,950,247 at June 30, 2026, compared with $37,169,881 at December 31, 2025. Total current liabilities of $15,733,716 exceeded total current assets of $2,865,536. Short-term borrowings, corporate bonds, and trade payables together account for the bulk of current obligations.
The company changed its name from OSR Holdings, Inc. to OSR Health, Inc. effective June 11, 2026. The filing states the name change did not alter any other provision of the certificate of incorporation or the terms of the common stock or warrants.